Biotechnology News

September 26, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pharmaceutical brand teams eager to maximize the price of the drugs establish intricate product launch sequencing strategies to target markets more favorable to higher value assessments.

September 26, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has...

September 26, 2012

TORONTO--(BUSINESS WIRE)--The most significant growth in the BRIC peripheral vascular market will be in aortic stent grafts and lower extremity devices.

September 26, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2012 sales and earnings conference call with institutional investors and analysts at 8 a.m. EDT on Friday...

September 26, 2012

WESTON, Mass. and STOCKHOLM, Sweden--(BUSINESS WIRE)--Biogen Idec and Sobi announce positive top-line results from Phase 3 study investigating long-lasting recombinant Factor IX Fc fusion protein in hemophilia B

September 26, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Xdynia LLC President Yuri Maricich will speak at the 2012 Mid-Atlantic Bio Conference on developing T-type calcium channel inhibitors to treat chronic pain, chemotherapy-induced neuropathy, and tremor

September 26, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac is pleased to announce the successful inspection of its Clinical Services operations located in Craigavon by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The inspection,...

September 26, 2012

MANNHEIM, Germany--(BUSINESS WIRE)--At the annual conference of the DGKL (Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin –see www.dgkl.de), Bruker today announced...

September 26, 2012

OXFORD, England--(BUSINESS WIRE)--PsiOxus Therapeutics has treated its first patient in its phase I/II clinical trial of its oncolytic vaccine, ColoAd1, for the treatment of metastatic solid tumours.

September 25, 2012

YOKOHAMA, Japan--(BUSINESS WIRE)--Business Wire is the official media partner for the BioJapan 2012. Breaking news releases, online press kits are available at Tradeshownews.com.

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the U.S. District Court of the District of Massachusetts has ruled in favor of Alnylam and has denied...

September 25, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, held the initial...

September 25, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced the pricing of the offering of US$600 million aggregate principal amount of 6.250% Senior Notes due 2019 (“Notes”) by its wholly-owned subsidiaries, Elan Finance...

September 25, 2012

BETHESDA, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--U.S. Food and Drug Administration (FDA) grants priority review status to AMITIZA® (lubiprostone) submission seeking approval for treatment of opioid-induced constipation.

September 25, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Tegal Corp. changes name to CollabRx, Inc. Ticker to change on Sept. 27, 2012 to CLRX

September 25, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that it has successfully completed the refinancing of its previously outstanding senior secured bank debt and reduced the company’s overall debt outstanding from approximately $...

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Announces Presentation of Data at North American Cystic Fibrosis Conference

September 25, 2012

RICHMOND, Va.--(BUSINESS WIRE)--Jeffrey M. Gallagher has been named as the new CEO for the Virginia Biotechnology Association.

September 25, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) applauds Sens. Robert Menendez (D-NJ) and Olympia Snowe (R-ME) and Reps. Jim Gerlach (R-PA) and Richard Neal (D-MA) for introducing the High Technology Small Business...

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--MedCap Advisors, mergers & acquisition and strategic consulting firm specializing in medical technology, releases discussion paper on the market penetration of biologics in orthopedics and beyond.

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and Neurotrauma, today hosted a ribbon cutting ceremony for the company’s new...

September 25, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech's HIPAA compliant hosting in the cloud for ForaCare, a Telehealth organization

September 25, 2012

HOUSTON--(BUSINESS WIRE)--Ensysce Biosciences Inc. announced today they have received a SBIR award of roughly $300,000 to optimize the formulation of their single walled carbon nanotube (SWCNT)/siRNA complex for therapeutic delivery. These funds...

September 25, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new study by Cutting Edge Information found that 69% of surveyed life sciences companies use the number of brands or products to support when determining MSL team size.

September 25, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--According to Cutting Edge Information, team structure and organizational position are vitally important to create effective, proactive pharmaceutical market research teams.

September 25, 2012

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research today announced that it has been awarded a contract with the Food and Drug Administration (FDA), to conduct bioequivalence studies

September 25, 2012

PHILADELPHIA--(BUSINESS WIRE)--Revitas Announces All-Star Lineup for Life Sciences Industry Summit; Top global industry leaders to discuss the changing pharmaceutical landscape

September 25, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources Group is pleased to announce a distinguished lineup of speakers who will be joining its well-regarded Competitive Landscape Seminar Series focusing on Biologics and Biosimilars on October 4,...

September 25, 2012

EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA, has announced the implementation and validation of Johnson Controls’ Metasys® building management system to provide the reliable monitoring and control of temperature and humidity

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scientists have named Genzyme one of the most highly regarded employers in the biopharmaceutical industry for the 10th consecutive year.

September 25, 2012

CAMBRIDGE, Mass. & BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the...

September 25, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that the average satisfaction rating for Biogen Idec / Elan’s Tysabri has increased...

September 25, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced it has joined AMDeC (Academy for Medical Development and Collaboration) as a Vendor Partner.

September 25, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for non-inflatable supraglottic airway products

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9 Expands Scientific Advisory Board to Advance Synthetic Biology

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Announces New Data on ALS-2200 in People With Hepatitis C, Supporting Advancement into Phase 2 All-Oral Studies in 2012; Ends Development of ALS-2158

September 25, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Atreca, Inc. receives $6 million from Bill & Melinda Gates Foundation to accelerate vaccine and therapeutics discovery and development. Initial partnership focus: malaria, HIV/AIDS, and tuberculosis.

September 25, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--CSA Medical Opens New Facility in Lexington, MA; triples space to advance customer training and product development

September 25, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics announces new trading symbol “OGEN” and trading of shares on both the OTCQB and OTCBB

September 25, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem‘s Evan L. Rosenfeld, VP of Medical and Scientific Affairs, Medical Device and Diagnostics, and Suzan Olson, Associate Director, Medical Devices, will attend the AdvaMED MedTech Conference

September 25, 2012

STATE COLLEGE, Pa.--(BUSINESS WIRE)--INDIGO Biosciences Inc., the premier provider of nuclear receptor products, has launched its new branding, “KNOW INDIGO,” and tagline, “The Nuclear Receptor Experts.”

September 25, 2012

TORONTO--(BUSINESS WIRE)--Penetration of biomaterial use with implant and periodontal procedures is still low in the Asia Pacific region in comparison to other global markets, leaving significant room for growth.

September 25, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--VitaPath Genetics, Inc., a privately held company leading the exploration of the Vitanome, announced healthcare industry veteran Catherine Burzik has been appointed Chair of its Board of Directors.

September 25, 2012

SEATTLE & SAN DIEGO--(BUSINESS WIRE)--NanoString launches a Single Cell Gene Expression solution that provides researchers with a flexible and highly sensitive approach to discovering differences in cell-to-cell gene expression profiles.

September 25, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced that its wholly-owned subsidiaries, Elan Finance public limited company (“Elan Finance”) and Elan Finance Corp. (“Elan Corp.” and together with Elan Finance, the...

September 25, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Recent Agreements with Specialty Pharmacy and Other Key Providers Across the Oncology Market Significantly Expand DARA's Coverage

September 25, 2012

TORONTO--(BUSINESS WIRE)--Momentum continues to build as Royal Liverpool and Broadgreen University Hospitals NHS Trust locks its place as one of the top finalists for the prestigious EHI Awards.